Three-dimensional CRISPR screening reveals epigenetic interaction with anti-angiogenic therapy.
Saved in:
| Title: | Three-dimensional CRISPR screening reveals epigenetic interaction with anti-angiogenic therapy. |
|---|---|
| Authors: | He MY; Tumour Angiogenesis and Microenvironment Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Halford MM; Tumour Angiogenesis and Microenvironment Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Liu R; Tumour Angiogenesis and Microenvironment Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia., Roy JP; Tumour Angiogenesis and Microenvironment Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia., Grant ZL; Epigenetics and Development Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia.; Gladstone Institutes, San Francisco, CA, USA., Coultas L; Epigenetics and Development Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia., Thio N; Bioinformatics Core, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Gilan O; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia., Chan YC; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Dawson MA; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Centre for Cancer Research, The University of Melbourne, Parkville, VIC, Australia.; Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Achen MG; Tumour Angiogenesis and Microenvironment Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.; Department of Surgery, Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, Australia.; St Vincent's Institute of Medical Research, Melbourne, VIC, Australia., Stacker SA; Tumour Angiogenesis and Microenvironment Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. Steven.Stacker@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia. Steven.Stacker@petermac.org.; Department of Surgery, Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, Australia. Steven.Stacker@petermac.org. |
| Source: | Communications biology [Commun Biol] 2021 Jul 15; Vol. 4 (1), pp. 878. Date of Electronic Publication: 2021 Jul 15. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
